India Medicine Sales Grow 12% to ₹70,180 Crore in Sept Quarter
India’s medicine sales rose 12% to ₹70,180 crore in the September quarter, a fourth straight double-digit gain led by cardiac, diabetes and cancer drugs.
India’s medicine sales rose 12% to ₹70,180 crore in the September quarter, a fourth straight double-digit gain led by cardiac, diabetes and cancer drugs.
Mankind Pharma’s Q2 FY27 net profit rose 37.7% to ₹716 crore on 17.3% revenue growth to ₹4,338 crore, led by cardiac and anti-diabetes demand in India, 33% export growth and a 210 bps EBITDA margin expansion to 27.1%.
Mankind Pharma Limited has appointed Anish Vanraj Bafna as an Independent Director on its Board, bringing more than three decades […]
Mankind Pharma Ltd. has announced the appointment of Dr. Tausif Ahmed as its Senior Vice President & Head of Clinical […]
Mankind Pharma has announced a strategic partnership with Innovent Biologics to exclusively license and commercialize Sintilimab, a cutting-edge PD-1 immunotherapy, […]
In two significant developments in India’s healthcare and pharmaceutical sectors, the Competition Commission of India (CCI) has approved the acquisition […]
Mankind Pharma Ltd. unveils its latest innovation – RAPID NEWS self-test kits, designed to address prevalent health issues including dengue, […]
Mankind Pharma has announced that it has entered into a definitive agreement to acquire a 100% stake in Bharat Serums […]
In a bid to expand its portfolio and venture into the lucrative surgical supplies market, Mankind Pharma has entered the […]
AstraZeneca Pharma India Limited and Mankind Pharma Limited have forged a groundbreaking partnership aimed at revolutionizing asthma treatment accessibility in […]
Mankind Pharma has named Tarun Kapoor as its new Vice President of Digital Transformation. Previously serving as the Head of […]
Mankind Pharma announced that one of its subsidiaries has acquired a majority stake in Upakarma Ayurveda Private Limited. Upakarma Ayurveda […]
Mankind Pharma is all set to launch the API factory by this year to promote affordable drug manufacturing in India. […]